Thursday’s Midday Stock Update: Orexigen (OREX), DryShips (DRYS), Titan Pharmaceuticals (TTNP), Cytori Therap (CYTX), Fuelcell Energy (FCEL)

By Carrie Williams

So far Thursday, June 14, NASDAQ is up 0.73% and the S&P is down -0.4%. Here are this morning’s most active stocks: Orexigen (NASDAQ:OREX), DryShips (NASDAQ:DRYS), Titan Pharmaceuticals (NASDAQ:TTNP), Cytori Therap (NASDAQ:CYTX) and Fuelcell Energy (NASDAQ:FCEL).

Orexigen is up 25% in midday trading to $0.15. Shares opened today at $0.12. The company has a 52-week low of $0.09 and a 52-week high of $0.00.

DryShips is up 12.47% in midday trading to $5.14. Shares opened today at $4.57. The company has a 52-week low of $0.98 and a 52-week high of $0.00.

Titan Pharmaceuticals is down -12.29% in midday trading to $1.00. Shares opened today at $1.14. The company has a 52-week low of $0.60 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.50, marking a 31.58% potential upside from current levels. In a report issued on May 18, Roth Capital analyst Scott Henry reiterated a Hold rating on TTNP, with a price target of $1.50, which implies an upside of 32% from current levels.

See today’s analyst top recommended stocks >>

Cytori Therap is down -7.76% in midday trading to $2.14. Shares opened today at $2.32. The company has a 52-week low of $2.07 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $4.33, marking a 86.64% potential upside from current levels. In a report issued on May 29, B.Riley FBR analyst Andrew D’silva maintained a Buy rating on CYTX, with a price target of $7, which implies an upside of 202% from current levels.

See today’s analyst top recommended stocks >>

Fuelcell Energy is down -6.68% in midday trading to $1.75. Shares opened today at $1.87. The company has a 52-week low of $1.10 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $3.75, marking a 100.53% potential upside from current levels. In a report issued on June 8, B.Riley FBR analyst Carter Driscoll maintained a Buy rating on FCEL, with a price target of $3.50, which represents a potential upside of 87% from where the stock is currently trading.

Trending Stocks Based on Insider Activity >>